Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?

Prediction of benefit from combined chemotherapy and the antiepidermal growth factor receptor cetuximab is a not yet solved question in head and neck squamous cell carcinoma (HNSCC). In a selected series of 14 long progression-free survival (PFS) and 26 short PFS patients by whole gene and microRNA...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Dis Markers
Main Authors: Bossi, Paolo, Siano, Marco, Bergamini, Cristiana, Cossu Rocca, Maria, Sponghini, Andrea P., Giannoccaro, Marco, Tonella, Luca, Paoli, Alessandro, Marchesi, Edoardo, Perrone, Federica, Pilotti, Silvana, Locati, Laura D., Canevari, Silvana, Licitra, Lisa, De Cecco, Loris
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2017
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5702394/
https://ncbi.nlm.nih.gov/pubmed/29259349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/6870614
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki